Updated: Aug 28, 2019
January National Provider Data Summary
There are currently 2 Trust’s that are not reporting RTT data:
Gloucestershire Hospitals NHS Foundation Trust (RTE)
Mid Essex Hospital Services NHS Trust (RQ8)
As the below heatmap and graph shows, there has been a substantial deterioration in RTT performance nationally when compared to January 2018.
Waiting List Size
As the below graph demonstrates, from March 2018 to January 2019 the total waiting list size increased from 3,843,182 to 4,162,948, an increase of 319,766 (8.32%).
St George's University Hospitals NHS Foundation Trust (RJ7) did return to reporting, but this only accounts for 29,052 of this variance.
Below is a table showing each reporting Trusts variance in waiting list size from March 2018 to January 2019, sorted by percentage variance (please click to view the whole table).
52 Week Waiters
The below heatmap shows how the number of 52-week waiters has changed nationally, with some areas such as the South West suffering a significant increase, the East Midlands are suffering from a less significant increase and other areas such as the North are managing to reduce their number of 52-week waiters.
Below is a table showing each reporting Trust’s variance in 52-week waiters from March 2018 to January 2019, sorted by percentage variance (please click to view the whole table).
Changes to the Individual Specialties
In regard to the waiting list size of the individual specialties:
Ophthalmology saw the highest percentage decrease of 2.15%, as well as the high decrease in the waiting list size going from 438,945 to 429,496, a decrease of 9,449 pathways.
Dermatology also saw a high decrease in the waiting list size going from 206,038 to 203,143, a decrease of 2,895 pathways (1.40%).
Neurosurgery saw a high percentage increase of 7.53% in the waiting list size, going from 30,541 to 32,841, an increase of 2,300 pathways.
Other, as a single specialty saw the largest increase of pathways, going from 857,977 to 864,749, an increase of 6,772 pathways (0.78%).
At the end of January 2019, 86.7% of patients waiting to start treatment (incomplete pathways) were waiting up to 18 weeks, thus not meeting the 92% standard.
The number of RTT patients waiting to start treatment at the end of January 2019 was 4.2 million patients. Of those, 2,157 patients were waiting more than 52 weeks.
For patients waiting to start treatment at the end of January 2019, the median waiting time was 7.8 weeks. The 92nd percentile waiting time was 22.5 weeks.
During January 2019, 316,997 RTT patients started admitted treatment and 1,182,524 started non-admitted treatment (completed pathways).
Performance has improved by 0.1% from December to January, but unfortunately, this may be as a result of the addition of new patients, as the waiting list size has also grown substantially.
Whilst there was a decrease in the waiting list size in October, November and December, unfortunately there has now been an increase in January. Perhaps this is indicative that whilst Trusts are doing all they can to reduce the waiting list size, there is only so much that can be done, with many Trusts experiencing increases in referrals that they simply can’t overcome.
The current variance from the March 18 position is 433,858 pathways, an 11.63% increase. When we remove those Trusts that have returned to reporting in this time, we see that these account for 172,606 pathways or 4.14% of the variance. This shows a true variance of 7.49%.
Based on their current position, 78 of the 178 (43.5%) providers that submitted data will achieve the March 2019 waiting list hold target.
Now that NHSE have revealed they plan to axe the current 18-week target in favour of an average waiting target instead, will this even be relevant soon?
Keep an eye out for our next blog taking a deep dive into the implications of the adoption of the proposed new average wait target.